TRYPSIN TREATMENT MAY IMPAIR THE INTERFACIAL ACTIVATION ACTION OF LIPOPROTEIN-LIPASE

被引:5
作者
TASHIRO, J
KOBAYASHI, J
SHIRAI, K
SAITO, Y
NAKAMURA, H
MORIMOTO, Y
YOSHIDA, S
机构
[1] CHIBA UNIV, DEPT INTERNAL MED 2, 1-8-1 INOHANA, CHUO KU, CHIBA 260, JAPAN
[2] MITSUBISHI CHEM IND LTD, RES CTR, MACHIDA, TOKYO 194, JAPAN
关键词
D O I
10.1093/oxfordjournals.jbchem.a123788
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipoprotein lipase was expressed in Chinese hamster ovary (CHO) cells transfected with human lipoprotein lipase cDNA. The lipoprotein lipase retained tributyrin, water-soluble substrate, hydrolyzing activity (esterase activity). The catalytic action of this enzyme was studied by monitoring the esterase activity. The esterase activity was enhanced 4.5-fold by the addition of triolein emulsified with Triton X-100. This process was named interfacial activation. Treatment of LPL with trypsin (100-mu-g/ml, 37-degrees-C for 10 min) caused the loss of the triolein hydrolyzing activity without that of the esterase activity. The esterase activity of trypsin-treated LPL was not enhanced by the addition of the triolein emulsion. The trypsin-treated LPL retained the ability to bind to very low density lipoproteins (VLDL). These results are consistent with the idea that LPL has a catalytic site and a lipid interface recognition site, and that the enzyme undergoes interfacial activation, in which the concealed catalytic site is revealed after the enzyme binds to the surface. Based on this hypothesis, the results obtained suggest that trypsin nicking may impair the interfacial activation process and cause the loss of the lipase activity.
引用
收藏
页码:509 / 514
页数:6
相关论文
共 17 条
[1]  
BELFRAGE P, 1969, J LIPID RES, V10, P341
[2]   LIPOPROTEIN-LIPASE - MODIFICATION OF ITS KINETIC-PROPERTIES BY MILD TRYPTIC DIGESTION [J].
BENGTSSON, G ;
OLIVECRONA, T .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1981, 113 (03) :547-554
[3]  
BENGTSSONOLIVER.G, 1981, EUR J BIOCHEM, V161, P281
[4]   HYPERTRIGLYCERIDEMIA ASSOCIATED WITH DEFICIENCY OF APOLIPOPROTEIN-C-II [J].
BRECKENRIDGE, WC ;
LITTLE, JA ;
STEINER, G ;
CHOW, A ;
POAPST, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (23) :1265-1273
[5]  
Brunzell JD, 1989, METABOLIC BASIS INHE, P1165
[6]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[7]   INTERCHANGE OF APOLIPOPROTEINS BETWEEN CHYLOMICRONS AND HIGH-DENSITY LIPOPROTEINS DURING ALIMENTARY LIPEMIA IN MAN [J].
HAVEL, RJ ;
KANE, JP ;
KASHYAP, ML .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (01) :32-38
[8]   AUTOIMMUNE HYPERCHYLOMICRONEMIA [J].
KIHARA, S ;
MATSUZAWA, Y ;
KUBO, M ;
NOZAKI, S ;
FUNAHASHI, T ;
YAMASHITA, S ;
SHO, N ;
TARUI, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (19) :1255-1259
[9]  
KINNUNEN PKJ, 1977, MED BIOL, V55, P187
[10]   LIPOPROTEIN-LIPASE WITH A DEFECT IN LIPID INTERFACE RECOGNITION IN A CASE WITH TYPE-I HYPERLIPEMIA [J].
KOBAYASHI, J ;
SHIRAI, K ;
SAITO, Y ;
YOSHIDA, S .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1989, 19 (05) :424-432